2025421
Congress Takehiko Kaneko, CMO of Heartseed, to Speak at ISCT 2025 Annual Meeting
2025414
Congress Keiichi Fukuda, CEO, to Speak at the 25th World Congress of the International Society for Heart Research (ISHR)
2025313
Other Heartseed has started CEO column, "TOP MESSAGE", on Investor Relation section of its website.
202523
PR Heartseed Announces Enrollment Completion in Phase 1/2 Clinical Trial using HS-001, an Investigational Stem Cell-Derived Therapy for Advanced Heart Failure
